Literature DB >> 22505866

Narcolepsy with cataplexy masked by the use of nicotine.

Matthew R Ebben1, Ana C Krieger.   

Abstract

This report describes a case of narcolepsy with cataplexy masked by the chronic use of cigarettes and nicotine patches. It has been described that narcoleptic smokers report relief of symptoms by smoking tobacco cigarettes. In addition, a case describing partial treatment of sleepiness using a nicotine patch in an adolescent with narcolepsy was recently reported in this journal. Our case adds to the growing literature that nicotine may be used to manage symptoms associated with narcolepsy.

Entities:  

Keywords:  Narcolepsy; cataplexy; masked; nicotine; sleepiness

Mesh:

Year:  2012        PMID: 22505866      PMCID: PMC3311418          DOI: 10.5664/jcsm.1780

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  14 in total

1.  Differential effects of the muscarinic M1 receptor agonist RS-86 and the acetylcholine-esterase inhibitor donepezil on REM sleep regulation in healthy volunteers.

Authors:  Christoph Nissen; Eric A Nofzinger; Bernd Feige; Bernhard Waldheim; Marc-Philipp Radosa; Dieter Riemann; Mathias Berger
Journal:  Neuropsychopharmacology       Date:  2006-06       Impact factor: 7.853

2.  Effect of specific M1, M2 muscarinic receptor agonists on REM sleep generation.

Authors:  J Velazquez-Moctezuma; J C Gillin; P J Shiromani
Journal:  Brain Res       Date:  1989-11-27       Impact factor: 3.252

3.  Motoneuron properties during motor inhibition produced by microinjection of carbachol into the pontine reticular formation of the decerebrate cat.

Authors:  F R Morales; J K Engelhardt; P J Soja; A E Pereda; M H Chase
Journal:  J Neurophysiol       Date:  1987-04       Impact factor: 2.714

4.  Role of cholinergic mechanisms in states of wakefulness and sleep.

Authors:  E F Domino; K Yamamoto; A T Dren
Journal:  Prog Brain Res       Date:  1968       Impact factor: 2.453

5.  Dose-dependent effects of transdermal nicotine on early morning awakening and rapid eye movement sleep time in nonsmoking normal volunteers.

Authors:  J C Gillin; M Lardon; C Ruiz; S Golshan; R Salin-Pascual
Journal:  J Clin Psychopharmacol       Date:  1994-08       Impact factor: 3.153

6.  The rat ponto-medullary network responsible for paradoxical sleep onset and maintenance: a combined microinjection and functional neuroanatomical study.

Authors:  Romuald Boissard; Damien Gervasoni; Markus H Schmidt; Bruno Barbagli; Patrice Fort; Pierre-Hervé Luppi
Journal:  Eur J Neurosci       Date:  2002-11       Impact factor: 3.386

7.  A novel approach to treating morning sleep inertia in narcolepsy.

Authors:  Kanika Bagai; Beth A Malow
Journal:  J Clin Sleep Med       Date:  2010-02-15       Impact factor: 4.062

Review 8.  Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization.

Authors:  Edward D Levin; F Joseph McClernon; Amir H Rezvani
Journal:  Psychopharmacology (Berl)       Date:  2005-10-12       Impact factor: 4.530

9.  Acute effects of transdermal nicotine on sleep architecture, snoring, and sleep-disordered breathing in nonsmokers.

Authors:  D G Davila; R D Hurt; K P Offord; C D Harris; J W Shepard
Journal:  Am J Respir Crit Care Med       Date:  1994-08       Impact factor: 21.405

10.  The familial risk and HLA susceptibility among narcolepsy patients in Hong Kong Chinese.

Authors:  Lei Chen; S Y Y Fong; Ching W Lam; Nelson L S Tang; Margaret H L Ng; Albert M Li; C K W Ho; Suk-Hang Cheng; Kin-Mang Lau; Yun Kwok Wing
Journal:  Sleep       Date:  2007-07       Impact factor: 5.849

View more
  3 in total

1.  [Narcolepsy].

Authors:  G Mayer
Journal:  Nervenarzt       Date:  2014-01       Impact factor: 1.214

Review 2.  Current Understanding of Narcolepsy 1 and its Comorbidities: What Clinicians Need to Know.

Authors:  Lois E Krahn; Phyllis C Zee; Michael J Thorpy
Journal:  Adv Ther       Date:  2021-12-11       Impact factor: 3.845

Review 3.  Orexin 1 receptor antagonists in compulsive behavior and anxiety: possible therapeutic use.

Authors:  Emilio Merlo Pich; Sergio Melotto
Journal:  Front Neurosci       Date:  2014-02-13       Impact factor: 4.677

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.